Corvus Pharmaceuticals, Inc. · NASDAQ:CRVS
Miller Richard A Md bought 6,932 Corvus Pharmaceuticals, Inc. shares (Form 4)
Traded May 18, 2026 · Filed May 20, 2026
On May 18, 2026, Miller Richard A Md (Director, President and CEO) bought 6,932 Corvus Pharmaceuticals, Inc. shares at an average US$12.04 for US$83,453, leaving 1,195,035 shares. Filed May 20, 2026 (Form 4).
- Bought
- 6,932 shares
- Price
- US$12.04 average (US$12.01 to US$12.05)
- Value
- US$83,453
- Holding after
- 1,195,035 shares (held indirectly)
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | Buy | 5,000 | US$12.05 | 1,193,103 | Indirect |
| May 18, 2026 | Common Stock | Buy | 1,932 | US$12.01 | 1,195,035 | Indirect |
Source
Related
- Corvus Pharmaceuticals, Inc.
- Miller Richard A Md
- Corvus Pharmaceuticals, Inc. shareholders
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Moore David Scott · Jun 15, 2026
- Schedule 13G · Sirenia Capital Management LP · May 15, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026